Biora Therapeutics Gets Positive Interim Data From Clinical Trial Of BT-600 With NaviCap; Stock Down

(RTTNews) - Biotech company, Biora Therapeutics, Inc. (BIOR), announced on Thursday that it has achieved positive interim results from the single-ascending dose clinical trial of BT-600. https://www.nasdaq.com/articles/biora-therapeutics-gets-positive-interim-data-from-clinical-trial-of-bt-600-with-navicap